TD Asset Management Inc Purchases 42,408 Shares of CVS Health Corporation $CVS

TD Asset Management Inc lifted its position in CVS Health Corporation (NYSE:CVS) by 3.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,263,369 shares of the pharmacy operator’s stock after buying an additional 42,408 shares during the period. TD Asset Management Inc’s holdings in CVS Health were worth $95,245,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CVS. SOA Wealth Advisors LLC. increased its stake in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 131 shares during the last quarter. Alteri Wealth LLC grew its holdings in shares of CVS Health by 3.2% during the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after purchasing an additional 131 shares in the last quarter. Holistic Financial Partners increased its position in shares of CVS Health by 4.1% in the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after purchasing an additional 133 shares during the last quarter. Symmetry Partners LLC raised its stake in CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS opened at $76.12 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The stock’s 50 day simple moving average is $78.35 and its 200 day simple moving average is $77.02. The firm has a market cap of $96.84 billion, a price-to-earnings ratio of 55.16, a PEG ratio of 0.77 and a beta of 0.50.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter last year, the business earned $1.19 earnings per share. The business’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is currently 192.75%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on CVS shares. Robert W. Baird increased their price target on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. The Goldman Sachs Group raised their price target on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Bank of America reduced their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Finally, Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a research report on Tuesday, January 6th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.